Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1

被引:44
作者
Heath, C
Cross, NCP
机构
[1] Hammersmith Hosp, Imperial Coll, Fac Med, Dept Haematol, London W12 ONN, England
[2] Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England
[3] Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
关键词
D O I
10.1074/jbc.M308743200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 8p11 myeloproliferative syndrome is an aggressive disorder caused by FGFR1 fusion proteins resulting from a subset of acquired translocations that target chromosome band 8p11. These chimeric proteins have constitutive FGFR1 tyrosine kinase activity and are believed to deregulate hemopoietic development in a manner analogous to BCR-ABL in chronic myeloid leukemia. Here we have studied the role of STAT proteins in transformation mediated by the most common of these fusions, ZNF198-FGFR1. We found that STATs 1, 3, and 5 were activated constitutively in ZNF198-FGFR1-transformed Ba/F3 cells and that STATs 2, 4, and 6 were also tyrosine-phosphorylated. Induction of dominant negative STAT mutants showed that activation of STAT5, but not STATs 1 or 3, was essential for the anti-apoptotic effect of ZNF198-FGFR1 and that STAT5 activation is essential for the elevated levels of BclXL in transformed cells. STAT5 activation was also shown to be required for continued cell cycle progression of BaF3/ZNF198-FGFR1 cells in conditions of cytokine deprivation and for up-regulation of the DNA repair protein Rad51. These findings suggest a critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.
引用
收藏
页码:6666 / 6673
页数:8
相关论文
共 35 条
[1]   The oncogenic fusion protein-tyrosine kinase ZNF198/fibroblast growth factor receptor-1 has signaling function comparable with interleukin-6 cytokine receptors [J].
Baumann, H ;
Kunapuli, P ;
Tracy, E ;
Cowell, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :16198-16208
[2]   Signal transducer and activator of transcription proteins in leukemias [J].
Benekli, M ;
Baer, MR ;
Baumann, H ;
Wetzler, M .
BLOOD, 2003, 101 (08) :2940-2954
[3]   STATs in oncogenesis [J].
Bowman, T ;
Garcia, R ;
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (21) :2474-2488
[4]   Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl [J].
Carlesso, N ;
Frank, DA ;
Griffin, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :811-820
[5]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[6]   The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins [J].
Demiroglu, A ;
Steer, EJ ;
Heath, C ;
Taylor, K ;
Bentley, M ;
Allen, SL ;
Koduru, P ;
Brody, JP ;
Hawson, G ;
Rodwell, R ;
Doody, ML ;
Carnicero, F ;
Reiter, A ;
Goldman, JM ;
Melo, JV ;
Cross, NCP .
BLOOD, 2001, 98 (13) :3778-3783
[7]   Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder:: The first fusion gene involving BCR but not ABL [J].
Fioretos, T ;
Panagopoulos, I ;
Lassen, C ;
Swedin, A ;
Billström, R ;
Isaksson, M ;
Strömbeck, B ;
Olofsson, T ;
Mitelman, F ;
Johansson, B .
GENES CHROMOSOMES & CANCER, 2001, 32 (04) :302-310
[8]   Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis [J].
Fukada, T ;
Hibi, M ;
Yamanaka, Y ;
TakahashiTezuka, M ;
Fujitani, Y ;
Yamaguchi, T ;
Nakajima, K ;
Hirano, T .
IMMUNITY, 1996, 5 (05) :449-460
[9]  
Grillot DAM, 1997, J IMMUNOL, V158, P4750
[10]   8p12 stem cell myeloproliferative disorder:: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways [J].
Guasch, G ;
Ollendorff, V ;
Borg, JP ;
Birnbaum, D ;
Pébusque, MJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (23) :8129-8142